Patent ID: 11872276
Assignee: INSTITUT PASTEUR
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 15:
16. The method of preventing ZIKV and DENV infections in a human subject according to claim 14, wherein the T-cell epitopes are ZIKV-DENV cross-reactive epitopes comprising or consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 5, 6, 12, 14, 15, 17-19, 23, 24, 27, 28, 33-35, 40, 41, 46, 48-50, 52-55, 57, 59, 60, 62, 64, 67, 69, 72, 73, 84, 85 and 86-91.